Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Observational

Dental Implant Osteointegrated With The Residual Root

NCT06671678 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2013-01
Last updated
2024-11-04

Condition(s) studied

Dental Implant FailedOsteointegrationDental Crowns

Study summary

This case report presents the long-term prognosis of an implant resulting in late failure with an osteointegrated root remnant on the fixture 11 years after implant placement. A 68-year-old female patient experienced issues with a maxillary right 4-unit implant-supported bridge placed 11 years ago. During removal, an osteointegrated root remnant was discovered on the middle supporting implant, which had been inadvertently placed over it. Clinicians should be cautious with retained root remnants, as they may impact osteointegration. However, both the implant and root fragment were osteointegrated without adverse effects.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient with dental implants placed in contact with residual roots Exclusion Criteria: * Lack of retained root remnants * Lack of dental implants

Primary outcome measure(s)

  • Dental Implant Osteointegrated With The Residual Root — From enrollment to the end of treatment at 11 years
    The prognosis of the osseointegration status of the retained root remnant and dental implant over an 11-year follow-up period. Whether osseointegration has occurred will be verified based on follow-up radiographic images and periodically recorded examination data. Evaluation criteria include implant stability, compatibility with surrounding bone and soft tissues, and potential inflammatory reactions around the root remnant. These measures are intended to understand the long-term integration of the implant and root remnant.

Trial sites (1)

FacilityCityRegionStatus
Ege University Faculty of Dentistry Department of Prosthodontics Izmir Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06671678 on ClinicalTrials.gov ↗ ← All trials in Turkey